National Planning Corporation’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-225
| Closed | -$207K | – | 530 |
|
|
2017
Q3 | $207K | Hold |
225
| – | – | 0.02% | 625 |
|
|
2017
Q2 | $208K | Buy |
225
+13
| +6% | +$12K | 0.02% | 669 |
|
|
2017
Q1 | $201K | Sell |
212
-2
| -0.9% | -$1.9K | 0.02% | 643 |
|
|
2016
Q4 | $204K | Buy |
214
+17
| +9% | +$16.2K | 0.02% | 622 |
|
|
2016
Q3 | $171K | Buy |
197
+17
| +9% | +$14.8K | 0.01% | 600 |
|
|
2016
Q2 | $132K | Buy |
180
+20
| +13% | +$14.7K | 0.01% | 632 |
|
|
2016
Q1 | $168K | Buy |
160
+31
| +24% | +$32.6K | 0.01% | 593 |
|
|
2015
Q4 | $99K | Buy |
129
+53
| +70% | +$40.7K | 0.01% | 690 |
|
|
2015
Q3 | $152K | Buy |
+76
| New | +$152K | 0.01% | 582 |
|
|
2015
Q1 | – | Sell |
-3
| Closed | -$2.51K | – | 1901 |
|
|
2014
Q4 | $2.51K | Buy |
+3
| New | +$2.51K | ﹤0.01% | 2529 |
|